Neuroone Medical Technologies is trading at $1.98 (+7.03%) in pre-market, rebounding after several consecutive down sessions.
- The move appears to be driven by broader risk sentiment rather than a direct company-specific catalyst, as no new earnings or FDA updates were reported.
- U.S. equity futures are trending higher, with the S&P 500, Nasdaq, and Dow Jones all showing gains in pre-market trading.